Does the Russell Viper Venom time test provide a rapid estimation of the intensity of oral anticoagulation? A cohort study (original) (raw)

A novel prothrombin time method to measure all non-vitamin K-dependent oral anticoagulants (NOACs)

Kerstin Arbring

Upsala Journal of Medical Sciences, 2017

View PDFchevron_right

Simple and rapid assay for effect of the new oral anticoagulant (NOAC) rivaroxaban: preliminary results support further tests with all NOACs

claudio gonzalez

Thrombosis Journal, 2014

View PDFchevron_right

Urgent Need to Measure Effects of Direct Oral Anticoagulants: Table

Jeffrey Weitz

Circulation, 2016

View PDFchevron_right

Measuring non-vitamin K antagonist oral anticoagulant levels: When is it appropriate and which methods should be used?

Ludovic Drouet

International Journal of Stroke, 2016

View PDFchevron_right

Point-of-Care Coagulation Testing for Assessment of the Pharmacodynamic Anticoagulant Effect of Direct Oral Anticoagulant

Alexander Kasper

Therapeutic Drug Monitoring, 2014

View PDFchevron_right

Laboratory testing in the era of direct or non-vitamin k antagonist oral anticoagulants: a practical guide to measuring their activity and avoiding diagnostic errors

Emmanuel Favaloro

Seminars in thrombosis and hemostasis, 2015

View PDFchevron_right

Patients' serum and urine as easily accessible samples for the measurement of non-vitamin k antagonist oral anticoagulants

Christel Weiss

Seminars in thrombosis and hemostasis, 2015

View PDFchevron_right

Recent guidelines and recommendations for laboratory assessment of the direct oral anticoagulants (DOACs): is there consensus?

Emmanuel Favaloro

Clinical chemistry and laboratory medicine : CCLM / FESCC, 2015

View PDFchevron_right

Measurement of non-vitamin K antagonist oral anticoagulants in patient plasma using Heptest-STAT coagulation method

Christel Weiss

Therapeutic Drug Monitoring, 2014

View PDFchevron_right

Position paper on laboratory testing for patients taking new oral anticoagulants. Consensus document of FCSA, SIMeL, SIBioC and CISMEL1)

Rita C Santoro

Clinical Chemistry and Laboratory Medicine, 2012

View PDFchevron_right

Laboratory tests during direct oral anticoagulant treatment? No

Elena Ricciardi, Antonella Scalera

Internal and Emergency Medicine, 2013

View PDFchevron_right

Determination of Direct Oral Anticoagulants from Human Serum Samples

Christel Weiss

Seminars in Thrombosis and Hemostasis, 2013

View PDFchevron_right

Coagulation testing in patients using anticoagulants

Daan van de Kerkhof

View PDFchevron_right

Measuring the anticoagulant effects of target specific oral anticoagulants—reasons, methods and current limitations

Alexander Kasper

Journal of Thrombosis and Thrombolysis, 2013

View PDFchevron_right

Selection and assessment of patients treated with the novel oral anticoagulant drugs: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis

GUALTIERO PALARETI

Journal of Thrombosis and Haemostasis, 2013

View PDFchevron_right

Monitoring the Effects and Antidotes of the Non-vitamin K Oral Anticoagulants

Rahmat AR

Arrhythmia & Electrophysiology Review, 2015

View PDFchevron_right

Methods for detection of direct oral anticoagulants and their role in clinical practice

Aivars Lejnieks

Cor et Vasa

View PDFchevron_right

Selection and assessment of patients treated with the novel oral anticoagulant drugs: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemo

Gualtiero Palareti, Anna Falanga

Journal of Thrombosis and Haemostasis, 2013

View PDFchevron_right

Novel Oral Anticoagulants: Agent Selection and Patient Monitoring

Antonis Manolis

Hospital Chronicles, 2013

View PDFchevron_right

Direct oral anticoagulants (DOACs): From the laboratory point of view

Sandra Supraha Goreta

Acta Pharmaceutica, 2022

View PDFchevron_right

Measurement of Anticoagulation in Patients on Dabigatran, Rivaroxaban, and Apixaban Therapy by Novel Automated Thrombelastography

Ramin Artang

TH open, 2021

View PDFchevron_right

Point-of-Care Testing in Oral Anticoagulant Monitoring

Jennifer Lafata

Disease Management and Health Outcomes, 1999

View PDFchevron_right

Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus Paper

Job Harenberg

Thrombosis and haemostasis, 2024

View PDFchevron_right

Rivaroxaban and other novel oral anticoagulants: pharmacokinetics in healthy subjects, specific patient populations and relevance of coagulation monitoring

Stephan Schwers

Thrombosis Journal, 2013

View PDFchevron_right

Laboratory testing and/or monitoring of the new oral anticoagulants/antithrombotics: for and against?

Emmanuel Favaloro

Clinical Chemistry and Laboratory Medicine, 2000

View PDFchevron_right

Nonvitamin K antagonist oral anticoagulant activity: challenges in measurement and reversal

Michele Mercuri

Critical Care, 2016

View PDFchevron_right

Anti-Xa and Anti-IIa Drugs Alter International Normalized Ratio Measurements: Potential Problems in the Monitoring of Oral Anticoagulants

O. Iqbal

Clinical and Applied Thrombosis/Hemostasis, 2004

View PDFchevron_right

The vexed question of whether or not to measure levels of direct oral anticoagulants before surgery or invasive procedures

GUALTIERO PALARETI

Internal and emergency medicine, 2018

View PDFchevron_right

Laboratory assessment of the anticoagulant effects of the next generation of oral anticoagulants

Eduardo Ramacciotti

Journal of Thrombosis and Haemostasis, 2013

View PDFchevron_right

A Critical Evaluation of the Prothrombin Time for Monitoring Oral Anticoagulant Therapy

Tomas Lindahl

Pathophysiology of Haemostasis and Thrombosis, 2003

View PDFchevron_right

Position Paper on laboratory testing for patients on direct oral anticoagulants. A Consensus Document from the SISET, FCSA, SIBioC and SIPMeL

Benedetto Morelli

PubMed, 2018

View PDFchevron_right

Measuring or Monitoring of Novel Anticoagulants: Which Laboratory Test to Request?

Paul Dobesh

Current Emergency and Hospital Medicine Reports, 2013

View PDFchevron_right

Concept of a point of care test to detect new oral anticoagulants in urine samples

Christel Weiss

Thrombosis journal, 2013

View PDFchevron_right